首页 正文

Compromised quality of medicines: a regulatory failure

{{output}}
January 1, 2026, was a milestone of sorts in the Indian drug industry. As of that date, all manufacturers, small and large, are required to comply with the December 2023 amendments to Schedule M of the Drugs and Cosmetics Act, 1940, and Rules, 1945, that relat... ...